Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-17-002435
Filing Date
2017-11-20
Accepted
2017-11-20 16:08:37
Documents
71
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q biostar10q093017.htm 10-Q 935972
2 EX-31.1 ex31-1.htm EX-31.1 12589
3 EX-31.2 ex31-2.htm EX-31.2 12686
4 EX-32.1 ex32-1.htm EX-32.1 4533
5 EX-32.2 ex32-2.htm EX-32.2 4489
  Complete submission text file 0001185185-17-002435.txt   4710730

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bspm-20170930.xml EX-101.INS 1029641
7 XBRL TAXONOMY EXTENSION SCHEMA bspm-20170930.xsd EX-101.SCH 51522
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bspm-20170930_cal.xml EX-101.CAL 32423
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bspm-20170930_def.xml EX-101.DEF 232295
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bspm-20170930_lab.xml EX-101.LAB 290296
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bspm-20170930_pre.xml EX-101.PRE 232589
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 171213839
SIC: 2834 Pharmaceutical Preparations